HLA-ABC Antikörper (PE-Cy5.5)
Kurzübersicht für HLA-ABC Antikörper (PE-Cy5.5) (ABIN7673947)
Target
Alle HLA-ABC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- PE-Cy5.5 Anti-Human HLA-A,B,C Antibody
-
Aufreinigung
- 0
-
Reinheit
- 0
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Volume per test: 5μL. Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 μL of antibody per test (million cells in 100 μL staining volume or per 100 μL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0. 1 % sodium azide, 1 % BSA, pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- HLA-ABC
-
Andere Bezeichnung
- HLA-A,B,C
-
Hintergrund
-
Synonyms: MHC class I|Major Histocompatibility Class I
Background: MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.
-
Molekulargewicht
- 0
-
Gen-ID
- 3105
-
UniProt
- P04439, P01889, P10321
-
Pathways
- T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-